Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
Original languageEnglish
Patent number特許第5167408號
Publication statusPublished - 1800

Fingerprint

Bone Neoplasms
Anti-Idiotypic Antibodies
Breast Neoplasms
Antibodies
interleukin 20

Cite this

@misc{c6820d40b4664506abf1e6ef25546e13,
title = "Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases",
abstract = "Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.",
author = "Ming-Shi Chang",
year = "1800",
language = "English",
type = "Patent",
note = "特許第5167408號",

}

TY - PAT

T1 - Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

AB - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

M3 - Patent

M1 - 特許第5167408號

ER -